Dark Blue Therapeutics

Pioneering the next generation of precision medicines to deliver a portfolio of transformative cancer therapies. Dark Blue Therapeutics is an innovative drug discovery biotechnology company based in Oxford, UK. We have assembled a highly experienced team, whose expertise spans the breadth of drug development from discovery to approval. This expertise has been gained over many years in the industry and draws from biotech, large pharmaceutical companies and investment management. Dark Blue leverages ground-breaking cancer biology insights, from Oxford University, to discover and develop innovative precision medicines that exploit novel vulnerabilities and dependencies. With this deep, proprietary understanding of target biology...

Oncology,drug discovery,pharmaceuticals,precision medicine,biomarkers,biotechnology,dna damage repair,and immunooncology

Dark blue therapeutics operates in the Biotechnology research industry.

Dark blue therapeutics's revenue is 11m - 100m

Dark blue therapeutics has 11 - 50 employees.